Dec 12 (Reuters) - The U.S. Food and Drug Administration
has approved Innoviva's ( INVA ) oral antibiotic for common
sexually transmitted infection, offering patients a pill instead
of the injection that is currently the only recommended
treatment, the regulator said on Friday.